These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26122864)

  • 1. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
    Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
    Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
    López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
    Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.
    Martínez C; García-Martín E; Blanco G; Gamito FJ; Ladero JM; Agúndez JA
    Br J Clin Pharmacol; 2005 Jan; 59(1):62-9. PubMed ID: 15606441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
    Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2007 May; 63(5):463-9. PubMed ID: 17333159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes.
    Karaźniewicz-Łada M; Luczak M; Główka F
    Xenobiotica; 2009 Jun; 39(6):476-85. PubMed ID: 19480553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the relationship between polymorphisms in CYP2C8 and CYP2C9 and the pharmacokinetics of celecoxib.
    Prieto-Pérez R; Ochoa D; Cabaleiro T; Román M; Sánchez-Rojas SD; Talegón M; Abad-Santos F
    J Clin Pharmacol; 2013 Dec; 53(12):1261-7. PubMed ID: 23996211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
    Agúndez JA; García-Martín E; Martínez C
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):607-20. PubMed ID: 19422321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers.
    Cabaleiro T; Román M; Ochoa D; Talegón M; Prieto-Pérez R; Wojnicz A; López-Rodríguez R; Novalbos J; Abad-Santos F
    Drug Metab Dispos; 2013 Jan; 41(1):224-9. PubMed ID: 23118328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.
    Kirchheiner J; Meineke I; Freytag G; Meisel C; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2002 Jul; 72(1):62-75. PubMed ID: 12152005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro.
    Yu L; Shi D; Ma L; Zhou Q; Zeng S
    Biopharm Drug Dispos; 2013 Jul; 34(5):278-87. PubMed ID: 23536207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive analysis of polymorphisms from breastmilk shows that ibuprofen is safe during certain stages of breastfeeding.
    Rigourd V; Meritet JF; Seraissol P; Amirouche A; Hachem T; Serreau R
    Acta Paediatr; 2015 Sep; 104(9):e420-1. PubMed ID: 26096518
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative.
    Zajic SC; Jarvis JP; Zhang P; Rajula KD; Brangan A; Brenner R; Dempsey MP; Christman MF
    Pharmacogenet Genomics; 2019 Apr; 29(3):49-57. PubMed ID: 30562214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers - a pilot study in healthy volunteers.
    Kapedanovska Nestorovska A; Jakjovski K; Naumovska Z; Sterjev Z; Geskovska NM; Mladenovska K; Suturkova L; Dimovski A
    Acta Pharm; 2019 Sep; 69(3):399-412. PubMed ID: 31259734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
    Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
    Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.
    Kirchheiner J; Kudlicz D; Meisel C; Bauer S; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Aug; 74(2):186-94. PubMed ID: 12891229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
    Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
    Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?
    Durrmeyer X; Hovhannisyan S; Médard Y; Jacqz-Aigrain E; Decobert F; Barre J; Alberti C; Aujard Y; Danan C; Baud O
    PLoS One; 2010 Aug; 5(8):e12329. PubMed ID: 20808793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.